ERYTHROBLASTOSIS

This adverse event was reported 50 times

These drugs are most commonly taken by patients reporting ERYTHROBLASTOSIS:

# Drug Count
0 FUROSEMIDE 3
1 IMATINIB MESYLATE 3
2 LETROZOLE 3
3 LETROZOLE TABLETS 3
4 OLAPARIB 3
5 ROMIPLOSTIM 3
6 ALDESLEUKIN 2
7 AMOXICILLIN 2
8 DARBEPOETIN ALFA 2
9 EMAPALUMAB-LZSG 2
See all common drugs associated with ERYTHROBLASTOSIS

ERYTHROBLASTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EMAPALUMAB-LZSG 2 0.0084
1 ALDESLEUKIN 2 0.0016
2 IVOSIDENIB 1 0.0005
3 LAMIVUDINE AND ZIDOVUDINE 2 0.0003
4 ROMIPLOSTIM 3 0.0002
5 PERINDOPRIL ERBUMINE 1 0.0002
6 TAMOXIFEN CITRATE 1 0.0002
7 OLAPARIB 3 0.0001
8 PYRIDOSTIGMINE BROMIDE 1 0.0001
9 IMATINIB MESYLATE 3 0.0001
See all drugs enriched for association with ERYTHROBLASTOSIS